Cargando…

High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis

Microsporidiosis is an emerging opportunistic infection causing severe digestive disorders in immunocompromised patients. The aim of this study was to investigate the prevalence of intestinal microsporidia carriage among immunocompromised patients hospitalized at a major hospital complex in the Tuni...

Descripción completa

Detalles Bibliográficos
Autores principales: Messaoud, Mariem, Abbes, Salma, Gnaien, Mayssa, Rebai, Yasmine, Kallel, Aicha, Jemel, Sana, Cherif, Ghaya, Skhairia, Mohamed Amine, Marouen, Sonia, Fakhfekh, Najla, Mardassi, Helmi, Belhadj, Slaheddine, Znaidi, Sadri, Kallel, Kalthoum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996336/
https://www.ncbi.nlm.nih.gov/pubmed/33668221
http://dx.doi.org/10.3390/jof7030161
_version_ 1783670094237270016
author Messaoud, Mariem
Abbes, Salma
Gnaien, Mayssa
Rebai, Yasmine
Kallel, Aicha
Jemel, Sana
Cherif, Ghaya
Skhairia, Mohamed Amine
Marouen, Sonia
Fakhfekh, Najla
Mardassi, Helmi
Belhadj, Slaheddine
Znaidi, Sadri
Kallel, Kalthoum
author_facet Messaoud, Mariem
Abbes, Salma
Gnaien, Mayssa
Rebai, Yasmine
Kallel, Aicha
Jemel, Sana
Cherif, Ghaya
Skhairia, Mohamed Amine
Marouen, Sonia
Fakhfekh, Najla
Mardassi, Helmi
Belhadj, Slaheddine
Znaidi, Sadri
Kallel, Kalthoum
author_sort Messaoud, Mariem
collection PubMed
description Microsporidiosis is an emerging opportunistic infection causing severe digestive disorders in immunocompromised patients. The aim of this study was to investigate the prevalence of intestinal microsporidia carriage among immunocompromised patients hospitalized at a major hospital complex in the Tunis capital area, Tunisia (North Africa), and perform molecular epidemiology and population structure analyses of Enterocytozoon bieneusi, which is an emerging fungal pathogen. We screened 250 stool samples for the presence of intestinal microsporidia from 171 patients, including 81 organ transplant recipients, 73 Human Immunodeficiency Virus (HIV)-positive patients, and 17 patients with unspecified immunodeficiency. Using a nested PCR-based diagnostic approach for the detection of E. bieneusi and Encephalitozoon spp., we identified 18 microsporidia-positive patients out of 171 (10.5%), among which 17 were infected with E. bieneusi. Microsporidia-positive cases displayed chronic diarrhea (17 out of 18), which was associated more with HIV rather than with immunosuppression other than HIV (12 out of 73 versus 6 out of 98, respectively, p = 0.02) and correlated with extended hospital stays compared to microsporidia-negative cases (60 versus 19 days on average, respectively; p = 0.001). Strikingly, internal transcribed spacer (ITS)-based genotyping of E. bieneusi strains revealed high-frequency occurrence of ITS sequences that were identical (n = 10) or similar (with one single polymorphic site, n = 3) to rare genotype WL12. Minimum-spanning tree analyses segregated the 17 E. bieneusi infection cases into four distinct genotypic clusters and confirmed the high prevalence of genotype WL12 in our patient population. Phylogenetic analyses allowed the mapping of all 17 E. bieneusi strains to zoonotic group 1 (subgroups 1a and 1b/1c), indicating loose host specificity and raising public health concern. Our study suggests a probable common source of E. bieneusi genotype WL12 transmission and prompts the implementation of a wider epidemiological investigation.
format Online
Article
Text
id pubmed-7996336
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79963362021-03-27 High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis Messaoud, Mariem Abbes, Salma Gnaien, Mayssa Rebai, Yasmine Kallel, Aicha Jemel, Sana Cherif, Ghaya Skhairia, Mohamed Amine Marouen, Sonia Fakhfekh, Najla Mardassi, Helmi Belhadj, Slaheddine Znaidi, Sadri Kallel, Kalthoum J Fungi (Basel) Article Microsporidiosis is an emerging opportunistic infection causing severe digestive disorders in immunocompromised patients. The aim of this study was to investigate the prevalence of intestinal microsporidia carriage among immunocompromised patients hospitalized at a major hospital complex in the Tunis capital area, Tunisia (North Africa), and perform molecular epidemiology and population structure analyses of Enterocytozoon bieneusi, which is an emerging fungal pathogen. We screened 250 stool samples for the presence of intestinal microsporidia from 171 patients, including 81 organ transplant recipients, 73 Human Immunodeficiency Virus (HIV)-positive patients, and 17 patients with unspecified immunodeficiency. Using a nested PCR-based diagnostic approach for the detection of E. bieneusi and Encephalitozoon spp., we identified 18 microsporidia-positive patients out of 171 (10.5%), among which 17 were infected with E. bieneusi. Microsporidia-positive cases displayed chronic diarrhea (17 out of 18), which was associated more with HIV rather than with immunosuppression other than HIV (12 out of 73 versus 6 out of 98, respectively, p = 0.02) and correlated with extended hospital stays compared to microsporidia-negative cases (60 versus 19 days on average, respectively; p = 0.001). Strikingly, internal transcribed spacer (ITS)-based genotyping of E. bieneusi strains revealed high-frequency occurrence of ITS sequences that were identical (n = 10) or similar (with one single polymorphic site, n = 3) to rare genotype WL12. Minimum-spanning tree analyses segregated the 17 E. bieneusi infection cases into four distinct genotypic clusters and confirmed the high prevalence of genotype WL12 in our patient population. Phylogenetic analyses allowed the mapping of all 17 E. bieneusi strains to zoonotic group 1 (subgroups 1a and 1b/1c), indicating loose host specificity and raising public health concern. Our study suggests a probable common source of E. bieneusi genotype WL12 transmission and prompts the implementation of a wider epidemiological investigation. MDPI 2021-02-24 /pmc/articles/PMC7996336/ /pubmed/33668221 http://dx.doi.org/10.3390/jof7030161 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Messaoud, Mariem
Abbes, Salma
Gnaien, Mayssa
Rebai, Yasmine
Kallel, Aicha
Jemel, Sana
Cherif, Ghaya
Skhairia, Mohamed Amine
Marouen, Sonia
Fakhfekh, Najla
Mardassi, Helmi
Belhadj, Slaheddine
Znaidi, Sadri
Kallel, Kalthoum
High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title_full High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title_fullStr High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title_full_unstemmed High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title_short High Frequency of Enterocytozoon bieneusi Genotype WL12 Occurrence among Immunocompromised Patients with Intestinal Microsporidiosis
title_sort high frequency of enterocytozoon bieneusi genotype wl12 occurrence among immunocompromised patients with intestinal microsporidiosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996336/
https://www.ncbi.nlm.nih.gov/pubmed/33668221
http://dx.doi.org/10.3390/jof7030161
work_keys_str_mv AT messaoudmariem highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT abbessalma highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT gnaienmayssa highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT rebaiyasmine highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT kallelaicha highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT jemelsana highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT cherifghaya highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT skhairiamohamedamine highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT marouensonia highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT fakhfekhnajla highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT mardassihelmi highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT belhadjslaheddine highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT znaidisadri highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis
AT kallelkalthoum highfrequencyofenterocytozoonbieneusigenotypewl12occurrenceamongimmunocompromisedpatientswithintestinalmicrosporidiosis